Eva Gaarsdal

625 total citations
19 papers, 514 citations indexed

About

Eva Gaarsdal is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Eva Gaarsdal has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Eva Gaarsdal's work include Hematopoietic Stem Cell Transplantation (12 papers), Immunotherapy and Immune Responses (5 papers) and Neutropenia and Cancer Infections (4 papers). Eva Gaarsdal is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Immunotherapy and Immune Responses (5 papers) and Neutropenia and Cancer Infections (4 papers). Eva Gaarsdal collaborates with scholars based in Denmark, Sweden and United States. Eva Gaarsdal's co-authors include Hans Erik Johnsen, Kirsten Nikolajsen, Inge Marie Svane, Anders Elm Pedersen, Mogens H. Claësson, Lene Meldgaard Knudsen, Dorte Nielsen, Claus Kamby, Louise Helene Søgaard Jensen and Søren Buus and has published in prestigious journals such as Cancer Immunology Immunotherapy, Genes Chromosomes and Cancer and Bone Marrow Transplantation.

In The Last Decade

Eva Gaarsdal

19 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Gaarsdal Denmark 13 280 252 220 126 52 19 514
Masayuki Takahashi Japan 10 371 1.3× 246 1.0× 148 0.7× 118 0.9× 43 0.8× 32 540
AW Wognum Netherlands 13 196 0.7× 127 0.5× 333 1.5× 161 1.3× 44 0.8× 22 559
Takako Tsujimoto Japan 9 248 0.9× 159 0.6× 203 0.9× 160 1.3× 19 0.4× 9 513
V Duvert France 8 306 1.1× 106 0.4× 184 0.8× 78 0.6× 36 0.7× 8 465
William B. Donnellan United States 13 183 0.7× 207 0.8× 398 1.8× 262 2.1× 36 0.7× 47 620
Kai Herrmann Germany 8 213 0.8× 79 0.3× 145 0.7× 293 2.3× 26 0.5× 8 538
Doug Joshua Australia 9 324 1.2× 224 0.9× 321 1.5× 201 1.6× 16 0.3× 14 558
H Hoogerbrugge Netherlands 10 263 0.9× 114 0.5× 225 1.0× 109 0.9× 40 0.8× 12 488
Philip McCoy United States 5 260 0.9× 194 0.8× 82 0.4× 93 0.7× 18 0.3× 11 383

Countries citing papers authored by Eva Gaarsdal

Since Specialization
Citations

This map shows the geographic impact of Eva Gaarsdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Gaarsdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Gaarsdal more than expected).

Fields of papers citing papers by Eva Gaarsdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Gaarsdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Gaarsdal. The network helps show where Eva Gaarsdal may publish in the future.

Co-authorship network of co-authors of Eva Gaarsdal

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Gaarsdal. A scholar is included among the top collaborators of Eva Gaarsdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Gaarsdal. Eva Gaarsdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Svane, Inge Marie, Anders Elm Pedersen, Julia S. Johansen, et al.. (2007). Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers. Cancer Immunology Immunotherapy. 56(9). 1485–1499. 89 indexed citations
2.
Pedersen, Anders Elm, Monika Gad, Mark R. Walter, et al.. (2005). Phenotypic and Functional Characterization of Clinical Grade Dendritic Cells Generated from Patients with Advanced Breast Cancer for Therapeutic Vaccination. Scandinavian Journal of Immunology. 61(2). 147–156. 40 indexed citations
3.
Svane, Inge Marie, Anders Elm Pedersen, Hans Erik Johnsen, et al.. (2004). Vaccination with p53-peptide?pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunology Immunotherapy. 53(7). 633–641. 103 indexed citations
4.
Svane, Inge Marie, Anders Elm Pedersen, Hans Erik Johnsen, et al.. (2004). Vaccination with Wild-Type p53 Peptide Pulsed-Dendritic Cells in Patients with Advanced Breast Cancer. Results from a Phase II Study. Journal of Immunotherapy. 27(6). S32–S33. 2 indexed citations
5.
Rasmussen, Thomas, et al.. (2002). Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients. Experimental Hematology. 30(1). 82–88. 17 indexed citations
6.
Poulsen, Tim Svenstrup, Asli Silahtaroglu, Eva Gaarsdal, et al.. (2001). Detection of illegitimate rearrangement within the immunoglobulin locus on 14q32.3 in B‐cell malignancies using end‐sequenced probes. Genes Chromosomes and Cancer. 32(3). 265–274. 12 indexed citations
7.
Knudsen, Lene Meldgaard, et al.. (2001). Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra‐apheresis. Journal of Clinical Apheresis. 16(3). 114–119. 39 indexed citations
8.
Jensen, Louise Helene Søgaard, et al.. (2000). A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF. Bone Marrow Transplantation. 26(7). 717–722. 27 indexed citations
9.
10.
Johnsen, Hans Erik, Ellen Taaning, Till Rasmussen, et al.. (1999). Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separation. Bone Marrow Transplantation. 24(12). 1329–1336. 18 indexed citations
11.
Knudsen, Lene Meldgaard, Louise Helene Søgaard Jensen, Lene Jarlbæk, et al.. (1999). Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.. PubMed. 84(6). 517–24. 28 indexed citations
12.
Knudsen, Lene Meldgaard, et al.. (1998). Evaluation of Mobilized CD34+ Cell Counts to Guide Timing and Yield of Large-Scale Collection by Leukapheresis. Journal of Hematotherapy. 7(1). 45–52. 24 indexed citations
13.
Knudsen, Lene Meldgaard, et al.. (1996). Improved Priming for Mobilization of and Optimal Timing for Harvest of Peripheral Blood Stem Cells. Journal of Hematotherapy. 5(4). 399–406. 35 indexed citations
14.
Hansen, Per Boye, Hans Erik Johnsen, Elisabeth Ralfkiær, et al.. (1995). Short Term rhG-CSF Priming; Before Chemotherapy Does Mobilize Blood Progenitors But Does Not Prevent Chemotherapy Induced Myelotoxicity: A Randomized Study of Patients with Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 19(5-6). 453–460. 7 indexed citations
15.
16.
Knudsen, Helle, et al.. (1995). Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.. PubMed. 16(3). 373–9. 19 indexed citations
17.
Johnsen, Hans Erik, et al.. (1994). Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.. PubMed. 22(1). 80–6. 9 indexed citations
18.
Johnsen, Hans Erik, et al.. (1993). Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.. PubMed. 7(9). 1402–8. 4 indexed citations
19.
Johnsen, Hans Erik, Per Boye Hansen, Torben Plesner, et al.. (1992). Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.. PubMed. 10(3). 229–34. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Takahashi Breakdown of academic impact, for papers by AW Wognum Breakdown of academic impact, for papers by Takako Tsujimoto Breakdown of academic impact, for papers by V Duvert Breakdown of academic impact, for papers by William B. Donnellan Breakdown of academic impact, for papers by Kai Herrmann Breakdown of academic impact, for papers by Doug Joshua Breakdown of academic impact, for papers by H Hoogerbrugge Breakdown of academic impact, for papers by Philip McCoy
Rankless by CCL
2026